Trials / Completed
CompletedNCT05414955
Boom-IBD Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Boomerang Medical · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility study of neuromodulation in patients with IBD.
Detailed description
The study will evaluate responses of patients with IBD treated with neuromodulation at various intervals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neuromodulation | Neuromodulation |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2024-12-06
- Completion
- 2024-12-06
- First posted
- 2022-06-10
- Last updated
- 2025-06-29
Locations
8 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05414955. Inclusion in this directory is not an endorsement.